IL3RA and systemic mastocytosis: Pardanani and colleagues studied 58 SM cases, including indolent SM, aggressive SM, SM with associated hematological neoplasm, and mast cell leukemia; CD123 was detected by immunohistochemistry in 100%, 61%, 57%, and 0% of cases, respectively [42].